Stephen L. Silvestro - May 15, 2025 Form 4 Insider Report for OptimizeRx Corp (OPRX)

Role
Chief Commercial Officer
Signature
/s/ Marion Odence-Ford, by Power of Attorney
Stock symbol
OPRX
Transactions as of
May 15, 2025
Transactions value $
$0
Form type
4
Date filed
5/19/2025, 04:03 PM
Previous filing
Mar 4, 2025
Next filing
Aug 25, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Silvestro Stephen L Chief Commercial Officer C/O OPTIMIZERX CORPORATION, 260 CHARLES STREET, SUITE 302, WALTHAM /s/ Marion Odence-Ford, by Power of Attorney 2025-05-19 0001773461

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPRX Common Stock Award $0 +46.9K +38.7% $0.00 168K May 15, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPRX Stock Option Award $0 +80.9K $0.00 80.9K May 15, 2025 Common Stock 80.9K $10.65 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on May 15, 2026, which is the first anniversary of the date of grant.
F2 The stock option vests in three equal annual installments beginning May 15, 2026, the first anniversary of the grant date.

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.